Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Edgar B. Cepeda"'
Autor:
Isabel Fabregat, T. Dediulia, Joan Fernando, Edgar B. Cepeda, Gustavo Egea, Esther Bertran, Estanislao Navarro
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853:1205-1218
Hepatocellular carcinoma (HCC) cells with a mesenchymal phenotype show an asymmetric subcellular distribution of the chemokine receptor CXCR4, which is required for cell migration and invasion. In this work we examine the mechanisms that regulate the
Autor:
Edgar B. Cepeda, Andrea Malfettone, Joan Fernando, Conrado M. Fernández-Rodríguez, Esther Bertran, Patricia Sancho, Gianluigi Giannelli, Giulia Raimondi, Pedro M. Fernández-Salguero, Angels Fabra, Isabel Fabregat, Alberto Álvarez-Barrientos, Roser Vilarrasa-Blasi
Publikováno v:
International Journal of Cancer. 136:E161-E172
The multikinase inhibitor sorafenib is the only effective drug in advanced cases of hepatocellular carcinoma (HCC). However, response differs among patients and effectiveness only implies a delay. We have recently described that sorafenib sensitizes
Autor:
Joan, Fernando, Andrea, Malfettone, Edgar B, Cepeda, Roser, Vilarrasa-Blasi, Esther, Bertran, Giulia, Raimondi, Àngels, Fabra, Alberto, Alvarez-Barrientos, Pedro, Fernández-Salguero, Conrado M, Fernández-Rodríguez, Gianluigi, Giannelli, Patricia, Sancho, Isabel, Fabregat
Publikováno v:
International journal of cancer. 136(4)
The multikinase inhibitor sorafenib is the only effective drug in advanced cases of hepatocellular carcinoma (HCC). However, response differs among patients and effectiveness only implies a delay. We have recently described that sorafenib sensitizes